Translational Drug Development, LLC specializes in preclinical services for oncology medicine development. Founded in 2003 and located in Scottsdale, Arizona, the company provides expertise in regulatory strategy, clinical trial design, and execution tailored specifically for oncology-focused organizations. It offers clients an integrated suite of tools that streamline the research process from preclinical development to regulatory submission. This includes access to over 300 tumor models, bioanalytical support, and advanced equipment for efficacy testing. By facilitating efficient patient recruitment and ensuring alignment with clinical and regulatory standards, Translational Drug Development plays a pivotal role in advancing oncology research and improving the chances of successful drug development.
CyMedica develops and commercializes innovative products that target joint injuries and the resulting muscle atrophy. Its mission is to address this problem with proprietary neuromuscular electrical stimulation. The company's platform technology utilizes the first closed-loop power control systems to provide patients with comfortable yet aggressive treatment.
It was founded in 2013 and headquartered in Scottsdale, Arizona.
NP Photonics, Inc. designs and produces optical light sources for sensing, medical, and research and development markets. It offers fiber and single-frequency lasers, amplified spontaneous emission sources, fiber amplifiers, and light sources. It offers its products through distributors in Australia, Belgium, France, Germany, Israel, Japan, South Korea, Spain, Sweden, Denmark, Iceland, Norway, Finland, the Netherlands, the People's Republic of China, and the United Kingdom. NP Photonics, Inc. was formerly known as NP Photonic Technologies, LLC and it changed its name in August 2000. The company was founded in 1998 and is based in Tucson, Arizona.